graphenefrontiers - internet of...
TRANSCRIPT
http://graphenefrontiers.com
Confidential and Proprietary
Medical biosensors play a major role in improving patients' quality of life. Global Medical Biosensors market forecasted to grow at CAGR 10.16% 2013-2018
Biosensors: $21B
1st Gen POC Diagnostics: Not Good Enough
• Limited Sensitivity
• Slow
• Inaccurate
Problem
Next Gen POC Diagnostics: Quantum Leap
Confidential and Proprietary
Graphene Field Effect Transistor (GFET) chips and Reader Device
Devices: GFET
GFET = Graphene Field Effect Transistor
Confidential and Proprietary
Nobel Prize in Physics 2010
Confidential and Proprietary
ELISA GFET
Limit of Detection (LOD) 1-20pg/ml 100x-1000x better
than ELISA
Ability to Multiplex No (1 antibody per run) Yes
Speed May take hours for
incubation and processing Sample to results in minutes
Cost Expensive Optical Readers All electronic, lower cost
Ease of Use Trained Lab Tech Needed After sample obtained, the rest is automated
Specificity of detection Relies on secondary detection antibody
Higher false positives
Specific and direct detection – all electronic
GF SIX BIOSENSOR PLATFORM
Graphene Frontiers Biosensors and IoT
GF Biosensors will transform healthcare and enable: • Healthcare technology growth
• Healthcare connectivity
• Epidemiology studies at national level • Big Data analytics
GF Biosensors will enable: (continued)
• Connection to CDC and generate alerts when infectious diseases arise in certain areas
• Easy and affordable diagnostics in rural areas
• Connection between small clinics and large medical centers to treat difficult diseases
Graphene Frontiers Biosensors and IoT
http://graphenefrontiers.com
Confidential and Proprietary
Mike Patterson, CEO [email protected]
Victoria Tsai, SVP Business Development and Tech R&D